摘要
目的观察介入超声治疗甲状腺囊性病变的临床效果,探讨甲状腺囊性病变治疗的新方法。方法采用彩色多普勒超声诊断仪,探头频率7.5～12 MHz,硬化剂为无水酒精,注入硬化剂为抽出囊液的1/2左右,比较治疗后3、6、12个月各组的疗效以及甲状腺激素(FT3、FT4)、促甲状腺激素(TSH)的变化情况。结果全部入选患者进针成功率100%,4例患者出现一过性声音嘶哑,其他未见明显并发症发生。术后随访3个月、6个月、1年,各随访时间疗效比较差异不明显。随访期间发现T3、T4和TSH术后均较术前有显著变化,P<0.05。结论超声介入治疗甲状腺囊性病变具有较好的疗效,微创、安全、易被患者接受,是一种首选的治疗方法,值得广泛推广和应用。
Objective To observe the clinical effect of involvement ultrasonic treatment thyroid cystic lesions, and to explore the new methods for treatment thyroid cystic lesions. Methods By using Color Doppler Ultrasound probe for the 7.5- 12 MHz, hardening agent was anhydrous alcohol, as a hardening agent into the fluid out of the bag about 1/2, after treatment, 6, 12 months, the efficacy and thyroid hormones （FT3, FT4）, thyroid-stimulating hormone （TSH） changes were compared in each group. Results All patients enrolled into the needle success rate was 100%, 4 patients had transient hoarseness, no other significant complications occurred. Patients were followed up 3 months, 6 months, 1 year, compared the efficacy of the follow-up time was not significantly different. Found during follow-up T3, T4 and TSH after surgery than before surgery had changed significantly, P 〈 0.05. Conclusion Percutaneous treatment of thyroid cystic lesions has good effect, minimally invasive, safe, easily patients, is a preferred method of treatment, it is widely promoted and applied.
出处
《中国现代医生》
2012年第6期47-48,共2页
China Modern Doctor
基金
浙江省湖州市科学技术局2011年第三批科技计划项目
名称:超声引导下乳腺病变空心针穿刺活检技术的临床应用研究(2011YS43)
关键词
介入性超声
甲状腺囊性病变
硬化剂
Interventional ultrasound
Thyroid cystic lesions
Hardening agent
